Status:
UNKNOWN
Segmentectomy vs Lobectomy
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborating Sponsors:
Regina Elena Cancer Institute
Istituto Europeo di Oncologia
Conditions:
Non-small Cell Lung Cancer Stage I
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Actual indications for stage Ia NSCLC patients suggest lobectomy and lymphadenectomy. On the other hand, recent studies reported non-inferiority of segmentectomy in case of nodule \< 2cm or with groun...
Eligibility Criteria
Inclusion
- Adenocarcinoma or squamous cell carcinoma
- cStage cIA with or without nodal upstaging
- lymphoadenectomy
- age \> 18 years old
- Radical resection
- anatomical resection (lobectomy or segmentectomy)
- PET CT done
Exclusion
- Nodal or distant metastasis confirmed before surgery
- Pure solid GGO
- Follow up \< 12 months
- Bilobectomy/pneumonectomy
- Trans fissure tumor
- Multiple lung tumors
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06180239
Start Date
January 1 2017
End Date
December 31 2024
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marco Chiappetta
Roma, Italy, 00168